Related Experiment Video
Updated: Jul 26, 2025

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
Published on: March 25, 2022
Post-COVID-19 cholangiopathy: Current understanding and management options
Fadl H Veerankutty1, Kushan Sengupta2, Mukul Vij3
1Institute of Liver Disease and Transplantation, Dr. Rela Institute and Research Centre, Chennai 600044, India. fadl_05@yahoo.com.
Post-coronavirus disease 2019 (COVID-19) cholangiopathy (PCC) is a rare complication causing liver issues. Early findings suggest antiplatelet therapy may improve liver function in PCC patients.
Area of Science:
- Hepatology
- Virology
- Gastroenterology
Background:
- Post-coronavirus disease 2019 (COVID-19) cholangiopathy (PCC) is a rare, severe complication of COVID-19.
- PCC presents as cholestasis in patients without prior liver disease during recovery.
- The exact cause of PCC is not fully understood, but SARS-CoV-2's effect on cholangiocytes is suspected.
Purpose of the Study:
- To review the current understanding of PCC.
- To discuss its pathophysiology, clinical features, and management.
Main Methods:
- Literature review of PCC.
- Analysis of clinical manifestations and treatment outcomes.
Main Results:
- PCC pathogenesis is unclear, potentially involving SARS-CoV-2 targeting cholangiocytes.
- PCC resembles but is distinct from secondary sclerosing cholangitis.
- Standard treatments have shown limited success; antiplatelet therapy shows promise.
Conclusions:
- PCC is a unique entity requiring further research.
- Effective management strategies for PCC are still evolving.
- PCC can lead to end-stage liver disease and necessitate transplantation.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...